Cedilla Therapeutics' Series A Round

Cedilla Therapeutics raised a round of funding on April 24, 2018. Investors include Third Rock Ventures.

Cedilla Therapeutics is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics. It works on cancer and other diseases caused by protein disregulation.…

Articles about Cedilla Therapeutics' Series A Round: